TRED Annual Report FY2016

22 NSU OFFICE OF TECHNOLOGY TRANSFER NSU Technologies NSU is able to recognize high-potential technologies, assess their technical and commercial feasibility, secure patent protection, and conduct transactions with commercialization partners for the ultimate benefit of the public. NSU technologies that are ready for commercialization include • portfolio of abuse-deterrent pharmaceutical compositions • diagnostic for genetic mutations • early detection of bed sores • fall prediction model • therapies for treatment of heart failure • image compression and encryption • portfolio of small-molecule cancer therapeutics • portfolio of novel drug delivery methods for anaphylaxis • novel method to diagnose complex immune diseases • novel method for modulating oncolytic viruses